Home » Stocks » LCI

Lannett Company, Inc. (LCI)

Stock Price: $9.64 USD 0.85 (9.67%)
Updated Jan 27, 2021 4:00 PM EST - Market closed
After-hours: $9.65 +0.01 (0.10%) Jan 27, 7:06 PM
Market Cap 366.55M
Revenue (ttm) 544.88M
Net Income (ttm) -27.71M
Shares Out 39.07M
EPS (ttm) -0.71
PE Ratio n/a
Forward PE 13.46
Dividend n/a
Dividend Yield n/a
Trading Day January 27
Last Price $9.64
Previous Close $8.79
Change ($) 0.85
Change (%) 9.67%
Day's Open 8.74
Day's Range 8.71 - 10.70
Day's Volume 1,439,278
52-Week Range 4.90 - 10.70

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PRNewsWire - 1 day ago

PHILADELPHIA, Jan. 27, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2021 second quarter on Wednesday, February 3,...

PRNewsWire - 1 month ago

PHILADELPHIA, Dec. 7, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced the closing of a $30 million asset-backed revolving credit facility with Wells Fargo Bank, National...

PRNewsWire - 1 month ago

PHILADELPHIA, Nov. 30, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that the company used a portion of its existing cash on hand to pay off, in full, the remaining $4...

Zacks Investment Research - 2 months ago

Let's see if Lannett Company (LCI) stock is a good choice for value-oriented investors right now from multiple angles.

Zacks Investment Research - 2 months ago

Lannett (LCI) delivered earnings and revenue surprises of -45.45% and -2.63%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Seeking Alpha - 2 months ago

Lannett Company, Inc. (LCI) CEO Tim Crew on Q1 2021 Results - Earnings Call Transcript

PRNewsWire - 2 months ago

PHILADELPHIA, Nov. 4, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2021 first quarter ended September 30, 2020. "We view our fiscal 20...

Zacks Investment Research - 2 months ago

Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PRNewsWire - 3 months ago

PHILADELPHIA, Pa., Oct. 28, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2021 first quarter on Wednesday, Novembe...

The Motley Fool - 5 months ago

Better-than-expected top and bottom lines weren't enough to make investors happy for one key reason.

Seeking Alpha - 5 months ago

Lannett Company, Inc. (LCI) CEO Tim Crew on Q4 2020 Results - Earnings Call Transcript

24/7 Wall Street - 5 months ago

Earnings season has been winding down this week, but there are always some companies still reporting or offering guidance.

Other stocks mentioned: BOX, NTAP, SPLK, WSM
Benzinga - 5 months ago

Shares of Lannett (NYSE:LCI) moved lower by 7.6% in after-market trading after the company reported Q4 results.

PRNewsWire - 5 months ago

PHILADELPHIA, Aug. 26, 2020 /PRNewswire/ -- Lannett Company, Inc.

Benzinga - 5 months ago

On Wednesday, August 26, Lannett (NYSE: LCI) will release its latest earnings report.

PRNewsWire - 5 months ago

PHILADELPHIA, Aug. 19, 2020 /PRNewswire/ -- Lannett Company, Inc.

PRNewsWire - 5 months ago

PHILADELPHIA, Aug. 17, 2020 /PRNewswire/ -- Lannett Company, Inc.

PRNewsWire - 5 months ago

PHILADELPHIA, Aug. 17, 2020 /PRNewswire/ -- Lannett Company, Inc.

Seeking Alpha - 5 months ago

Lannett: Market Is Pricing The Worst Scenario, Why We Remain Invested

The Motley Fool - 6 months ago

Investors responded enthusiastically to the company's new generic distribution deal.

Market Watch - 6 months ago

Shares of Lannett Company Inc. LCI, -7.12% gained 0.2% after the company said it will cut 80 positions, about 8.5% of its total workforce, over concerns that its generic fluphenazine product w...

PRNewsWire - 6 months ago

PHILADELPHIA, July 13, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced a restructuring and cost savings plan. The initiatives include consolidating the research and deve...

PRNewsWire - 7 months ago

PHILADELPHIA, June 11, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today said that representatives from the company spoke with and received guidance from the U.S. Food and Drug Admi...

The Motley Fool - 7 months ago

Here's why a new initiative by the FDA to reduce drug prices is great for patients but should raise the alarm among pharmaceutical investors.

Other stocks mentioned: ANIP, MYL, PFE, TARO, TEVA
The Motley Fool - 8 months ago

The company released its earnings report for the third quarter of its fiscal year 2020.

Seeking Alpha - 8 months ago

Lannett Company, Inc. (LCI) CEO Timothy Crew on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 8 months ago

Lannett (LCI) delivered earnings and revenue surprises of 3.85% and 8.18%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 9 months ago

Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Motley Fool - 11 months ago

The generic-drug maker's revenue and earnings fell in Q2. But there were still several positives in Lannett's quarterly update.

Seeking Alpha - 11 months ago

Lannett Company, Inc.'s (LCI) CEO Tim Crew on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 11 months ago

Lannett (LCI) delivered earnings and revenue surprises of 0.00% and 5.82%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 11 months ago

Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 1 year ago

Elite is on track to become profitable for the first time

Other stocks mentioned: ATNX
Zacks Investment Research - 1 year ago

In the latest trading session, Lannett (LCI) closed at $9.01, marking a -1.64% move from the previous day.

Zacks Investment Research - 1 year ago

Investors need to pay close attention to Lannett (LCI) stock based on the movements in the options market lately.

Seeking Alpha - 1 year ago

Lannett: Building Success One Step At A Time

Market Watch - 1 year ago

Shares of Lannett Company Inc. LCI, +1.37% rallied 11% in premarket trading after it said a clinical trial for its experimental long-acting insulin biosimilar met the primary endpoints.

Seeking Alpha - 1 year ago

Lannett Company's (LCI) CEO Tim Crew on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Lannett (LCI) delivered earnings and revenue surprises of 10.00% and 4.88%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

In the latest trading session, Lannett (LCI) closed at $11.88, marking a -1% move from the previous day.

Zacks Investment Research - 1 year ago

Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 1 year ago

Lannet's (LCI) fiscal first-quarter 2020 results are likely to reflect strong performance of its anti-psychosis and cardiovascular drugs.

Zacks Investment Research - 1 year ago

Lannett (LCI) closed the most recent trading day at $12.26, moving +1.16% from the previous trading session.

Zacks Investment Research - 1 year ago

Is (LCI) Outperforming Other Medical Stocks This Year?

Zacks Investment Research - 1 year ago

Markets have turned volatile due to poor economic data and geopolitical tensions, here are five defensive stocks to boost your portfolio.

Other stocks mentioned: GEN, GO, NRG, USFD
Zacks Investment Research - 1 year ago

Lannett (LCI) closed at $12.18 in the latest trading session, marking a -0.9% move from the prior day.

The Motley Fool - 1 year ago

It's getting hot in Beyond Meat's kitchen, while Lannett takes a big blast of bearishness.

Other stocks mentioned: BYND
The Motley Fool - 1 year ago

Though major indexes rose, these companies got left behind.

Other stocks mentioned: CDE, MDR
The Motley Fool - 1 year ago

The generic drug specialist raised money through a debt offering that might be a little more complicated than necessary.

Zacks Investment Research - 1 year ago

As of late, it has definitely been a great time to be an investor Lannett Company.

About LCI

Lannett Company develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, centr... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
Founded
1942
CEO
Timothy Crew
Employees
954
Stock Exchange
NYSE
Ticker Symbol
LCI
Full Company Profile

Financial Performance

In 2020, LCI's revenue was $545.74 million, a decrease of -16.73% compared to the previous year's $655.41 million. Losses were -$33.37 million, -87.74% less than in 2019.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for LCI stock is "Hold." The 12-month stock price forecast is 7.75, which is a decrease of -19.61% from the latest price.

Price Target
$7.75
(-19.61% downside)
Analyst Consensus: Hold